Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2000
05/09/2000CA2011532C Formulation
05/09/2000CA1340987C Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime, processof preparation, their use as medicine and compositions containing same
05/09/2000CA1340986C 1,2,5,6,-tetrahydropyridine derivatives, method for preparing same, their use as medicine and compositions containing same
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024885A2 p53 MORPHOLINO-BASED ANTISENSE
05/04/2000WO2000024869A2 Methods for modulating cell fusion
05/04/2000WO2000024785A1 Substance for reduction of cholesterol as well as lipids content
05/04/2000WO2000024780A2 Compositions and methods for treating polycystic kidney disease
05/04/2000WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000WO2000024763A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/04/2000WO2000024762A1 Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumors
05/04/2000WO2000024761A1 Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them
05/04/2000WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF
05/04/2000WO2000024755A1 Ovary-specific genes and proteins
05/04/2000WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
05/04/2000WO2000024744A1 Bicyclic nitrogen heterocycles
05/04/2000WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers
05/04/2000WO2000024734A1 Lipoic acid derivatives and their use in treatment of disease
05/04/2000WO2000024728A1 Microbial transformation product
05/04/2000WO2000024724A1 Thiazole-derivatives
05/04/2000WO2000024719A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
05/04/2000WO2000024718A1 Serine protease inhibitor
05/04/2000WO2000024717A2 Isoquinoline derivatives
05/04/2000WO2000024714A1 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization
05/04/2000WO2000024710A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/04/2000WO2000024707A1 Substituted phenyl derivatives, their preparation and use
05/04/2000WO2000024426A1 Ribozymes used as prodrugs
05/04/2000WO2000024422A1 Process for producing glycolytic metabolism regulators
05/04/2000WO2000024419A1 Methods for enhancing wound healing
05/04/2000WO2000024412A2 Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/04/2000WO2000024410A1 Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
05/04/2000WO2000024409A1 Composition containing eugenol and polyphenols and use of such a composition for wound healing
05/04/2000WO2000024407A1 Non-fermented osmotic laxative for treating and preventing colorectal cancers
05/04/2000WO2000024405A1 Compounds and their therapeutic use with diabetic complications
05/04/2000WO2000024403A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000024402A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000024401A1 Fluticasone lotion having improved vasoconstrictor activity
05/04/2000WO2000024400A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof
05/04/2000WO2000024399A1 Compositions and methods employing r(-) fluoxetine and other active ingredients
05/04/2000WO2000024398A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000WO2000024397A1 Immunomodulatory drug composition
05/04/2000WO2000024396A1 Treatment of disorders of the outer retina
05/04/2000WO2000024395A1 New use of glutamate antagonists for the treatment of cancer
05/04/2000WO2000024394A1 Antitumor chrysene derivatives
05/04/2000WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000WO2000024391A2 Conductance of improperly folded proteins through the secretory pathway
05/04/2000WO2000024390A1 Method and composition for modulating amyloidosis
05/04/2000WO2000024389A2 Benzoquinoline derivatives useful as antibacterial agents
05/04/2000WO2000024388A2 Combination of 5-aminosalicylic acid and a budesonide, 6-methyl prednisolone or prednisolone for treating inflammatory disorders of the intestinal tract
05/04/2000WO2000024387A2 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid
05/04/2000WO2000024386A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000WO2000024384A1 Combined pharmaceutical estrogen-androgen-progestin
05/04/2000WO2000024383A1 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
05/04/2000WO2000024380A1 Microparticles containing peg and/or peg glyceryl esters
05/04/2000WO2000024378A1 Compositions of microspheres for wound healing
05/04/2000WO2000024376A1 Propofol composition
05/04/2000WO2000024374A1 Controlled release liquid delivery compositions with low initial drug burst
05/04/2000WO2000024373A1 O/w emulsion comprising an hydroxylated oil
05/04/2000WO2000024370A1 Dermatologic gels for the treatment of acne vulgaris and herpes simplex containing methenamine
05/04/2000WO2000024368A1 Reduction of hair growth
05/04/2000WO2000024366A1 Preparations for topical application of substances having antiandrogenic effect
05/04/2000WO2000024365A1 Treatment of skin with adenosine or adenosine analog
05/04/2000WO2000024362A2 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use
05/04/2000WO2000024361A2 Bis(haloethyl)aminobenzene derivatives
05/04/2000WO2000024360A2 Preparation and use of solidified oils
05/04/2000WO2000012139B1 Hypoxia regulated genes
05/04/2000WO2000012072A3 The use of fumaric acid derivatives in transplant medicine
05/04/2000WO2000010542A3 Utilization of pentaerythrityl nitrates together with phosphodiesterase-v-inhibitors, e.g. sildenafil
05/04/2000WO2000007997A8 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS
05/04/2000WO2000007593A8 Remedies or preventives for intractable epilepsy
05/04/2000WO2000007541A3 Use of xanthine derivatives for treating erectile disorder
05/04/2000WO2000006705A3 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
05/04/2000WO2000006579A3 Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity
05/04/2000WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
05/04/2000WO2000006139A3 Use of moclobemide and metabolites for treating and preventing substance abuse
05/04/2000WO2000006118A3 Short contact treatment of acne and photoaging with topical retinoids
05/04/2000WO2000006085A3 Compounds and methods
05/04/2000WO2000006082A3 Treatment of anxiety disorders
05/04/2000WO2000004868A3 Libraries of polyhydroxamates and their analogs
05/04/2000WO2000004862A3 Bioenhanced formulations comprising eprosartan in oral solid dosage form
05/04/2000WO2000003677A3 Use of bisphosphonates in the treatment of vascular restenosis
05/04/2000WO2000002897B1 Delta cleavage products and methods based thereon
05/04/2000WO2000002547A3 The treatment of renal colic with gaba analogs
05/04/2000WO2000002544A3 Use of piperine for treating skin pigmentation disorders
05/04/2000WO1999067430A3 Analytic substrates and antioxidative agents
05/04/2000WO1999067283A8 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/04/2000WO1999062888A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
05/04/2000WO1999062879A8 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
05/04/2000WO1999061066A3 Convection-enhanced delivery of aav vectors
05/04/2000WO1999060146A9 Adeno-associated virus vectors and uses thereof
05/04/2000WO1999059573A9 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
05/04/2000WO1999054286A3 Btk inhibitors and methods for their identification and use
05/04/2000WO1999043672A9 Inhibitors of phospholipase a2
05/04/2000WO1998025595A3 Aqueous drink composition comprising ibuprofen
1 ... 6323 6324 6325 6326 6327 6328 6329 6330 6331 6332 6333 6334 6335 6336 6337 6338 6339 6340 6341 6342 6343 ... 7860